Identification of small molecule inhibitors of anthrax lethal factor

The virulent spore-forming bacterium Bacillus anthracis secretes anthrax toxin composed of protective antigen (PA), lethal factor (LF) and edema factor (EF). LF is a Zn-dependent metalloprotease that inactivates key signaling molecules, such as mitogen-activated protein kinase kinases (MAPKK), to ultimately cause cell death. We report here the identification of small molecule (nonpeptidic) inhibitors of LF. Using a two-stage screening assay, we determined the LF inhibitory properties of 19 compounds. Here, we describe six inhibitors on the basis of a pharmacophoric relationship determined using X-ray crystallographic data, molecular docking studies and three-dimensional (3D) database mining from the US National Cancer Institute (NCI) chemical repository. Three of these compounds have Ki values in the 0.5–5 μM range and show competitive inhibition. These molecular scaffolds may be used to develop therapeutically viable inhibitors of LF.

[1]  S. H. Vosko,et al.  Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis , 1980 .

[2]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[3]  G. V. Vande Woude,et al.  Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Mock,et al.  Pharmacology: Screening inhibitors of anthrax lethal factor , 2002, Nature.

[5]  H. Khanna,et al.  A Dominant Negative Mutant of Bacillus anthracisProtective Antigen Inhibits Anthrax Toxin Action in Vivo * , 2001, The Journal of Biological Chemistry.

[6]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[7]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[8]  K D Paull,et al.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.

[9]  S. E. Hammond,et al.  Lethal Factor Active-Site Mutations Affect Catalytic Activity In Vitro , 1998, Infection and Immunity.

[10]  S. Leppla,et al.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Klimpel,et al.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  John A. Young,et al.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Jadwiga Bienkowska,et al.  Crystal structure of the anthrax lethal factor , 2001, Nature.

[14]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[15]  A. Becke.  Density-functional thermochemistry. , 1996 .

[16]  G. Boivin,et al.  Macrophage Apoptosis by Anthrax Lethal Factor Through p 38 MAP Kinase Inhibition , 2002 .

[17]  M. Mock,et al.  Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. , 1998, Biochemical and biophysical research communications.

[18]  George M. Whitesides,et al.  Designing a polyvalent inhibitor of anthrax toxin , 2001, Nature Biotechnology.

[19]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[20]  Lewis C Cantley,et al.  The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor , 2004, Nature Structural &Molecular Biology.

[21]  K. Klimpel,et al.  Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. , 1992, The Journal of biological chemistry.

[22]  Michael Karin,et al.  Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition , 2002, Science.

[23]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[24]  Dennis R. Salahub,et al.  Optimization of Gaussian-type basis sets for local spin density functional calculations. Part I. Boron through neon, optimization technique and validation , 1992 .

[25]  B. Sellman,et al.  Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax , 2001, Science.

[26]  John A. Young,et al.  Identification of the cellular receptor for anthrax toxin , 2001, Nature.